Vaccine News and Research

Latest Vaccine News and Research

Pharma IQ releases new infographic summary of results from industry survey

Pharma IQ is pleased to announce the release of a brand new infographic summary of the results from an industry survey conducted earlier this year.

From IQPC Ltd 19 Jun 2013

MMR booster does not result in worse JIA disease activity in children

Among children with juvenile idiopathic arthritis who had undergone primary immunization, the use of a measles-mumps-rubella booster compared with no booster did not result in worse JIA disease activity, according to a study in the June 19 issue of JAMA.

19 Jun 2013

International researchers solve three-dimensional structure of respiratory syncytial virus

Young children and the elderly are especially susceptible to respiratory syncytial virus. The three-dimensional structure of respiratory syncytial virus has been solved by an international team from Finland and Switzerland.

18 Jun 2013

University of Michigan poll: 61% of adults don't know when they last vaccinated against pertussis

Cases of pertussis, also known as whooping cough, are on the rise in the U.S., recently reaching their highest level in 50 years. The disease can be serious or even fatal to newborns who have not yet received vaccinations.

18 Jun 2013

Vaccine given to newborns 60% effective against rotavirus in Ghana

Mayo Clinic and other researchers have shown that a vaccine given to newborns is at least 60 percent effective against rotavirus in Ghana. Rotavirus causes fever, vomiting and diarrhea, which in infants can cause severe dehydration.

18 Jun 2013

Malaria control strategies: an interview with Sir Richard Feachem, Global Health Group, University of California, San Francisco

Exciting progress has been made in the global fight against malaria. The malaria map continues to shrink each year; in the last ten years four countries have been certified malaria-free, and thirty-four additional countries are now working towards malaria elimination targets.

17 Jun 2013

Experts raise awareness about the importance of flu vaccine

The last flu season arrived four weeks early, was more intense than expected and resulted in the deaths of more than 110 children in the United States. In an effort to get ahead of the upcoming flu season, experts at Montefiore Medical Center are raising awareness about the importance of the flu vaccine, which remains the best option to reduce a person's risk of contracting the virus. The flu season can start as early as late September and usually runs for about 12 to 15 weeks.

14 Jun 2013

Value of vaccinating children, young adults for influenza underestimated, experts say

The huge value of vaccinating more children and young adults for influenza is being seriously underestimated, experts say in a new report, while conventional wisdom and historic vaccine programs have concentrated on the elderly and those at higher risk of death and serious complications.

13 Jun 2013

New collaboration to advance cancer immunotherapy research

The Cancer Research Institute, the Ludwig Institute for Cancer Research and Immune Design, a biotech company focused on immune-based therapies for cancer and other human diseases, today announced that they have signed a collaboration agreement to advance cancer immunotherapy research.

13 Jun 2013

Background mortality rates can be used to communicate vaccine safety risks

In a study using the Vaccine Safety Datalink (VSD), investigators analyzed four years of data and determined that background mortality rates (rates of death irrespective of cause) are crucial in interpreting the numbers of deaths following vaccination.

12 Jun 2013

Viewpoints: Medicaid expansion 'makes sense'; Budget cuts hurt Alzheimer's research; Lack of transparency in generic Rx prices

The numbers in the Rand study ... should not be a surprise to people who have been paying attention. Numerous studies now, including in Missouri, have pointed to the simple reality of the policy implications of the ACA to argue for Medicaid expansion.

12 Jun 2013

Anti-nicotine vaccination can increase accumulation of nicotine in the brain, say neuroscientists

Researchers have yet again been sent back to the drawing board in the development of the much-sought-after vaccination for smokers, which would hypothetically inhibit the action of nicotine and its pleasure-producing chemical response in the brain.

12 Jun 2013

Johns Hopkins researchers develop experimental vaccine for TB meningitis

A team of Johns Hopkins researchers working with animals has developed a vaccine that prevents the virulent TB bacterium from invading the brain and causing the highly lethal condition TB meningitis, a disease that disproportionately occurs in TB-infected children and in adults with compromised immune system.

12 Jun 2013

Medicago gets Health Canada clearance to initiate Phase II clinical trial for H5N1 vaccine

Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced it has received clearance by Health Canada to initiate its Phase II dose-sparing clinical trial for an H5N1 Avian Influenza VLP vaccine candidate ("H5N1 vaccine").

11 Jun 2013

Children's Hospital & Research Center Oakland retains NIH ranking as 10th for research grants

Children's Hospital & Research Center Oakland is ranked 10th in the nation for research grants from the National Institutes of Health to children's hospitals. In 2012, Children's Hospital & Research Center Oakland received more than $15 million in awards from the NIH for 25 separate research grants - a 20.4 percent increase in funding compared to 2011.

11 Jun 2013

Mandatory influenza vaccination does not lead to excessive voluntary termination

Mandatory influenza (flu) vaccination, as a condition of employment, did not lead to excessive voluntary termination, according to a four-year analysis of vaccination rates at Loyola University Medical Center in Maywood, IL.

10 Jun 2013

NanoViricides files Orphan Drug application with FDA for DengueCide

NanoViricides, Inc. announced today that it has filed an Orphan Drug application with the Office of Orphan Product Development of the US FDA for DengueCide, its drug candidate for the treatment of dengue and dengue hemorrhagic fever.

10 Jun 2013

Nation's leading experts join forces to accelerate effective treatments for brain tumors

The nation's leading brain tumor and biotech industry experts again joined forces Friday, June 7, in a bid to accelerate more effective treatments for brain tumors and promote funding for the latest emerging therapies, as the Weill Cornell Brain and Spine Center and Voices Against Brain Cancer hosted its second annual Brain Tumor Biotech Summit.

10 Jun 2013

State highlights: Ore. schools face insurance exchange choice

Wal-Mart Stores Inc. wages are so low they force many of its employees onto the public doles, creating a drag on taxpayers and the economy, according to a new report from the staff of congressional Democrats. The report analyzes data from Wisconsin's Medicaid program, estimating that a single 300-person Wal-Mart Supercenter in that state likely costs taxpayers at least $904,542 per year and could cost up to $1,744,590 per year, or roughly $5,815 per employee (Lazo, 6/7).

10 Jun 2013

Large study of deep brain stimulation underway for Alzheimer's disease treatment

Together, Butler Hospital and Rhode Island Hospital are participating in The ADvance Study, a clinical trial investigating the use of deep brain stimulation as a treatment for patients with Alzheimer's disease.

10 Jun 2013

Vaccine News and Research

Latest Vaccine News and Research

Pharma IQ releases new infographic summary of results from industry survey

MMR booster does not result in worse JIA disease activity in children

International researchers solve three-dimensional structure of respiratory syncytial virus

University of Michigan poll: 61% of adults don't know when they last vaccinated against pertussis

Vaccine given to newborns 60% effective against rotavirus in Ghana

Malaria control strategies: an interview with Sir Richard Feachem, Global Health Group, University of California, San Francisco

Experts raise awareness about the importance of flu vaccine

Value of vaccinating children, young adults for influenza underestimated, experts say

New collaboration to advance cancer immunotherapy research

Background mortality rates can be used to communicate vaccine safety risks

Viewpoints: Medicaid expansion 'makes sense'; Budget cuts hurt Alzheimer's research; Lack of transparency in generic Rx prices

Anti-nicotine vaccination can increase accumulation of nicotine in the brain, say neuroscientists

Johns Hopkins researchers develop experimental vaccine for TB meningitis

Medicago gets Health Canada clearance to initiate Phase II clinical trial for H5N1 vaccine

Children's Hospital & Research Center Oakland retains NIH ranking as 10th for research grants

Mandatory influenza vaccination does not lead to excessive voluntary termination

NanoViricides files Orphan Drug application with FDA for DengueCide

Nation's leading experts join forces to accelerate effective treatments for brain tumors

State highlights: Ore. schools face insurance exchange choice

Large study of deep brain stimulation underway for Alzheimer's disease treatment

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in